Eliza FONG Li Shan

  • Senior Tutor

- Ph.D Bioengineering, Rice University, Houston, USA
- B.Eng. ( Bioengineering) with 1st Class Honors, National University of Singapore

Professional Work Experience

2010 - 2015 Ph.D. Candidate, Rice University, Houston, USA
2009 - 2010 Teaching Assistant, National University of Singapore

Research Interest

  1. Biomaterials
  2. Tumor Microenvironment
  3. Three-Dimensional Tumor Models
  4. Drug Testing

Selected Awards & Honours

2017

  • NUS Early Career Award

2014

  • BioScience Research Collaborative, Collaborative Shared Prize
  • Rice University Institute of Biosciences and Bioengineering travel Grant

2013

  • Society of Biomaterials STAR Award
  • Rice University Institute of Biosciences and Bioengineering Travel Grant
  • Cancer Biology Training Consortium (CABTRAC) Invited Participant

2012

  • Rice Bioengineering Department Outstanding Teaching Assistant Award
  • Rice University Institute of Biosciences and Bioengineering Travel Grant

2010 - 2015

  • National University of Singapore-Overseas Graduate Scholarship

2008/09 and 2005/06

  • Faculty of Engineering Dean’s List

Selected Journal Publications

  1. Fong EL, Toh TB, Lin X, Liu Z, Nurrul Abdullah L, Mohd Abdul Rashid Masturah Bte, Benoukraf T, Chow E, Huynh H, Yu H, Generation of Matched Patient-Derived Xenograft In Vitro-In Vivo Models using 3D Macroporous Hydrogels for the Study of Liver Cancer,Biomaterials. 2018 Jan
  2. .
  3. Fong EL, Harrington DA, Farach-Carson MC, Yu H. Heralding a New Paradigm in 3D Tumor ModelingBiomaterials. 2016 Sep.
  4. Fong EL, Wan X, Yang J, Morgado M, Mikos AG, Harrington DA, Navone NM, Farach-Carson MC. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactionsBiomaterials. 2016 Jan;77:164-72.
  5. Pan T, Fong EL, Martinez M, Harrington DA, Lin S-H, Farach-Carson MC, Satcher R, Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastasesCancer Letters, 2015 May
  6. Chang MA, Patel V, Gwede M, Morgado M, Tomasevich K, Fong EL, Farach-Carson MC, Delk NA, IL-1β induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cellsJournal of Cellular Biochemistry, 2014 Dec;115(12):2188-97
  7. Fong EL, Martinez M, Yang J, Mikos AG, Kasper FK, Harrington DA, Farach-Carson MC, Developing a Clinically Relevant Model of Bone Metastatic Prostate CancerMolecular Pharmaceutics, 2014 Apr; 11(7):2040-2050
  8. Fong EL, Santoro M, Farach-Carson MC, Kasper FK, Mikos AG, Tissue Engineering Perfusable Cancer ModelsCurrent Opinion in Chemical Engineering, 2014 Feb; 3:112-117
  9. Fong EL, Lamhamedi-Cherradi SE, Burdett E, Ramamoorthy V, Lazar AJ, Kasper FK, Farach-Carson MC, Vishwamitra D, Demicco EG, Menegaz BA, Amin HM, Mikos AG, Ludwig JA, Modeling Ewing Sarcoma Tumors in vitro with 3D scaffolds, PNAS, 2013 Apr; 110(16):6500-5.
  10. Fong EL, Brendan M. Watson, F. Kurtis Kasper, Antonios G. Mikos,Building Bridges: Leveraging Interdisciplinary Collaborations in the Development of Biomaterials to Meet Clinical Needs, Advanced Materials, 2012 Sep; 24(36):4995-5013
  11. Fong EL, Chan CK, Goodman SB. Stem Cell Homing in Musculoskeletal Injury. Biomaterials, 2011 Jan; 32(2):395-409
  12. Chatterjee DK, Fong EL, Zhang Y. Nanoparticles in Photodynamic Therapy: An Emerging ParadigmAdvanced Drug Delivery Reviews, 2008 Dec; 60(15):1627-37